• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Diagnostic tools
      • Research team
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Suzanne Reed

  • share 
  • tweet 
  • share 
  • share 

Publications

Reed Suzanne, Do Minh Thai, Lange Jens A., Koro Carol, Heinemann Klaas, Pregnancy and pregnancy outcomes in a prospective cohort study: Final Results from the Nexplanon Observational Risk Assessment Study (NORA) Contraception. 2022; 10.1016/j.contraception.2022.109920.
Reed Suzanne, Koro Carol, DiBello Julia, Becker Kerstin, Bauerfeind Anja, Franke Christian, Heinemann Klaas, Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism European Journal of Contraception & Reproductive Health Care. 2021; 1 - 8. 10.1080/13625187.2021.1987410 .
Reed Suzanne, Koro Carol, DiBello Julia, Becker Kerstin, Bauerfeind Anja, Franke Christian, Heinemann Klaas, Unintended pregnancy in users of nomegestrol acetate and 17β-oestradiol (NOMAC-E2) compared with levonorgestrel-containing combined oral contraceptives: final results from the PRO-E2 study European Journal of Contraception & Reproductive Health Care. 2021; 1-7. 10.1080/13625187.2021.1988923.
Reed Suzanne, Do Minh Thai, Lange Jens A., Koro Carol, Fox Michelle, Heinemann Klaas, Real world data on Nexplanon® procedure-related events: final results from the Nexplanon observational risk assessment study (NORA) Contraception. 2019; pii: S0010-7824(19)30131-3. 10.1016/j.contraception.2019.03.052.
Heinemann Klaas, Barnett Clare, Reed Suzanne, Moehner Sabine, Do Minh Thai, IUD use among parous women and risk of uterine perforation: a secondary analysis Contraception. 2017; Volume 95, Issue 6, Pages 605–607.
Heinemann Klaas, Moehner Sabine, Do Minh Thai, Reed Suzanne, Intrauterine Devices and the Risk of Uterine Perforations: Final Results from the EURAS-IUD 5-years study Pharmacoepidemiology and Drug Safety. 2016; Aug;25:(S3):3-680. 10.1002/pds.4070.
Heinemann Klaas, Moehner Sabine, Reed Suzanne, Do Minh Thai, Unwanted pregnancies in women using Intrauterine Devices: final results from the EURAS-IUD 5-years study Pharmacoepidemiology and Drug Safety. 2016; Aug;25:(S3):3-680. 10.1002/pds.4070.
Heinemann Klaas, Reed Suzanne, Moehner Sabine, Do Minh Thai, Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices. Contraception. 2015; Apr;91(4):280-3. 10.1016/j.contraception.2015.01.011.
Heinemann Klaas, Reed Suzanne, Moehner Sabine, Do Minh Thai, Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices. Contraception. 2015; 10.1016/j.contraception.2015.01.007.

sidebar

Executive Team

  • Clare Barnett
  • Karl Pauls
  • Michael Schultze
  • Alfred Pauls
  • Anja Bauerfeind
  • Do Minh Thai
  • Elisabeth Finger
  • Jens A. Lange

Management Board

  • Klaas Heinemann
  • Clare Barnett
  • Marc Pignot
  • Karl Pauls
  • Johanna Poppe

Project Management Team

  • Pauline De Corte
  • Lisa Eggebrecht
  • Maria Cabral
  • Anitha Pitchika
  • Mohammed Dagher

Search

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Diagnostic tools
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2023 ZEG Berlin

Impressum

Website by Laura Yeffeth.